- Home
- CLGN vs PASG Comparison
CLGN vs PASG Comparison
Compare CLGN & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- PASG
- Stock Information
- Founded
- CLGN 2004
- PASG 2017
- Country
- CLGN Israel
- PASG United States
- Employees
- CLGN N/A
- PASG N/A
- Industry
- CLGN Industrial Specialties
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- CLGN Health Care
- PASG Health Care
- Exchange
- CLGN Nasdaq
- PASG Nasdaq
- Market Cap
- CLGN 48.1M
- PASG 42.2M
- IPO Year
- CLGN N/A
- PASG 2020
- Fundamental
- Price
- CLGN $4.03
- PASG $0.60
- Analyst Decision
- CLGN Strong Buy
- PASG Strong Buy
- Analyst Count
- CLGN 2
- PASG 3
- Target Price
- CLGN $12.50
- PASG $8.00
- AVG Volume (30 Days)
- CLGN 12.0K
- PASG 886.7K
- Earning Date
- CLGN 11-27-2024
- PASG 03-03-2025
- Dividend Yield
- CLGN N/A
- PASG N/A
- EPS Growth
- CLGN N/A
- PASG N/A
- EPS
- CLGN N/A
- PASG N/A
- Revenue
- CLGN $650,000.00
- PASG N/A
- Revenue This Year
- CLGN N/A
- PASG N/A
- Revenue Next Year
- CLGN $692.59
- PASG N/A
- P/E Ratio
- CLGN N/A
- PASG N/A
- Revenue Growth
- CLGN N/A
- PASG N/A
- 52 Week Low
- CLGN $3.24
- PASG $0.45
- 52 Week High
- CLGN $6.75
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- CLGN 52.27
- PASG 43.68
- Support Level
- CLGN $3.79
- PASG $0.56
- Resistance Level
- CLGN $4.31
- PASG $0.64
- Average True Range (ATR)
- CLGN 0.21
- PASG 0.11
- MACD
- CLGN 0.02
- PASG -0.01
- Stochastic Oscillator
- CLGN 54.89
- PASG 8.69
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.